Discontinuation report NOVAHISTEX DH
| Report ID | 98371 |
| Drug Identification Number | 02049481 |
| Brand name | NOVAHISTEX DH |
| Common or Proper name | Novahistex DH |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | PHENYLEPHRINE HYDROCHLORIDE HYDROCODONE BITARTRATE |
| Strength(s) | 20MG 5MG |
| Dosage form(s) | SYRUP |
| Route of administration | ORAL |
| Packaging size | 100ml |
| ATC code | R05DA |
| ATC description | COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2020-03-31 |
| Actual discontinuation date | 2020-04-09 |
| Remaining supply date | 2020-03-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | last lot 8131851 expiry 2022-05-29 |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2020-08-04 | French | Compare |
| v3 | 2020-08-04 | English | Compare |
| v2 | 2019-11-11 | French | Compare |
| v1 | 2019-11-11 | English | Compare |
Showing 1 to 4 of 4